{"name":"Adenovir Pharma AB","slug":"adenovir-pharma-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"APD-209 Eye drops","genericName":"APD-209 Eye drops","slug":"apd-209-eye-drops","indication":"Treatment of dry eye disease","status":"phase_2"}]}],"pipeline":[{"name":"APD-209 Eye drops","genericName":"APD-209 Eye drops","slug":"apd-209-eye-drops","phase":"phase_2","mechanism":"APD-209 Eye drops are designed to reduce inflammation in the eye by inhibiting the action of a specific enzyme.","indications":["Treatment of dry eye disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQNnRpSzhxWHBzTVVpZ1QxMmdvODZyZy0tY25UY3VfeVJ1LTI5ZUI2d3NGSC1VOFBkclloS0YyeHIzWEgwRXBBcmQwOERJOWJvSlpfSmdDUkVOdmQ0bXRzWHhTeXgzbkRZMThFcm9lMEJJNk01UWc4aWEyajJBRDUzdUtZWDBWOHRLekVPQjY4M1FmcG1SOExtSHQ3TFpnR2hNM0tRWDM5VVY5a1dfQVRLZnRwa3FaQQ?oc=5","date":"2025-01-17","type":"regulatory","source":"OncLive","summary":"LOAd703 Oncolytic Adenovirus Receives FDA Fast Track Designation for Pancreatic Cancer - OncLive","headline":"LOAd703 Oncolytic Adenovirus Receives FDA Fast Track Designation for Pancreatic Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQMlRoR2l6YVJoQjc5dXJPZ1Rkd2RzWjN5OG9ramZvVjNnaVBxZ1dwdVJuc25sWDFXMUwyZGtGenZtamZfMUJ3T25WUDNIcUV1ZGdIRDJhYXp3X01HZVV6OE9PYXJlVnYzTnlXNC1xN00zOUhkVS00c3R0aGNINzUtbmt0a24wZUlZLWJjRDdRS1hIOW9hdEpING9hYzJvcXc?oc=5","date":"2025-01-17","type":"regulatory","source":"Targeted Oncology","summary":"FDA Grants Fast Track Designation to LOAd703 in Pancreatic Cancer - Targeted Oncology","headline":"FDA Grants Fast Track Designation to LOAd703 in Pancreatic Cancer","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}